Destruction Certificates and Quality Requirements in Clinical Trials
Destruction Certificates and Quality Requirements in Clinical Trials How to Manage Destruction Certificates and Quality Requirements for Clinical Trial Materials In clinical trials, the proper destruction of unused or returned Investigational Products (IPs) is a critical regulatory requirement. Equally important is the documentation that supports this process—specifically, the Destruction Certificate. These certificates, along with related…
Read More “Destruction Certificates and Quality Requirements in Clinical Trials” »